Cargando…
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for “Diabesity”
[Image: see text] Peptidic agonists of the glucagon-like peptide-1 receptor (GLP-1R) have gained a prominent role in the therapy of type-2 diabetes and are being considered for reducing food intake in obesity. Potential advantages of small molecules acting as positive allosteric modulators (PAMs) of...
Autores principales: | Decara, Juan M., Vázquez-Villa, Henar, Brea, José, Alonso, Mónica, Srivastava, Raj Kamal, Orio, Laura, Alén, Francisco, Suárez, Juan, Baixeras, Elena, García-Cárceles, Javier, Escobar-Peña, Andrea, Lutz, Beat, Rodríguez, Ramón, Codesido, Eva, Garcia-Ladona, F. Javier, Bennett, Teresa A., Ballesteros, Juan A., Cruces, Jacobo, Loza, María I., Benhamú, Bellinda, Rodríguez de Fonseca, Fernando, López-Rodríguez, María L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014410/ https://www.ncbi.nlm.nih.gov/pubmed/35349261 http://dx.doi.org/10.1021/acs.jmedchem.1c01842 |
Ejemplares similares
-
2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306),
an Orally Bioavailable Positive Allosteric Modulator of the Human
Dopamine D(1) Receptor for Parkinson’s Disease
por: García-Cárceles, Javier, et al.
Publicado: (2022) -
A new serotonin 5-HT(6) receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding
por: González-Vera, Juan A., et al.
Publicado: (2017) -
New Trends in Aging Drug Discovery
por: Benhamú, Bellinda, et al.
Publicado: (2022) -
PA02.19. Prospects of commercial utilization of water extracted Curcuma longa
por: Rajalakshmy, MR, et al.
Publicado: (2013) -
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)